Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases. (Q50082613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

3 references

25 September 2020

18 July 2021

26 October 2022

Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

main subject

cardiovascular disease

1 reference

1 reference

25 September 2020

1 reference

25 September 2020

cellular reprogramming

1 reference

18 July 2021

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Alberico L. Catapano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Siroon Bekkering

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

4

Mihai G Netea

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

2

Matthias Nahrendorf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Børge G. Nordestgaard

7

object named as

Børge G Nordestgaard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

author name string

Renate M Hoogeveen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Niels P Riksen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Menno P J de Winther

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Esther Lutgens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Erik S G Stroes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

publication date

1 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

7 October 2018

3 references

25 September 2020

18 July 2021

26 October 2022

7

1 reference

inferred from page(s)

published in

European Heart Journal

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

25 September 2020

18 July 2021

26 October 2022

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

issue

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

page(s)

3521-3527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 4.0 International

8 April 2020

copyright license

3 references

25 September 2020

18 July 2021

Inflammation in atherosclerosis

26 October 2022

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Cholesterol, inflammation and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Inflammation and immunity in diseases of the arterial tree: players and layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Myocardial infarction accelerates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Local proliferation dominates lesional macrophage accumulation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Macrophages in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Leukocyte count and coronary heart disease: implications for risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Increased microvascularization and vessel permeability associate with active inflammation in human atheromata

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Anti-inflammatory therapies for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Adaptive immunity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Inflammation and its resolution as determinants of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Monocytes in atherosclerosis: subsets and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Ischemic stroke activates hematopoietic bone marrow stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Effects of dyslipidaemia on monocyte production and function in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Innate immune memory: towards a better understanding of host defense mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Trained immunity: a memory for innate host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Innate immune recognition: mechanisms and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Specific memory within innate immune systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

The selection and function of cell type-specific enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Epigenetic Regulation of Monocyte and Macrophage Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

A decade of exploring the cancer epigenome - biological and translational implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Specific and Complex Reprogramming of Cellular Metabolism in Myeloid Cells during Innate Immune Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Metabolism and chromatin dynamics in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Epigenetics and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Metabolic Regulation of Histone Acetyltransferases by Endogenous Acyl-CoA Cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Immunometabolic Pathways in BCG-Induced Trained Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Macrophage Immunometabolism: Where Are We (Going)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Trained innate immunity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Citrullination of fibronectin in rheumatoid arthritis synovial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Glycoprotein 96 perpetuates the persistent inflammation of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Long-term activation of the innate immune system in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Anti-inflammatory therapy in chronic disease: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Arterial inflammation in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

From synovial tissue to peripheral blood: myeloid related protein 8/14 is a sensitive biomarker for effective treatment in early drug development in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Inflammation-induced foam cell formation in chronic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

The origin and properties of extracellular DNA: from PAMP to DAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Danger signaling in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Simvastatin with or without ezetimibe in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Non-invasive molecular imaging of vulnerable atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Epigenetic modifications as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX581

Monocyte count: a risk factor for coronary heart disease?

21 January 2018

1 reference

12 December 2020

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation

1 reference

12 December 2020

In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients

1 reference

12 December 2020

Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies

1 reference

12 December 2020

Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis

1 reference

12 December 2020

Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis

1 reference

12 December 2020

Macrophage death and defective inflammation resolution in atherosclerosis

1 reference

12 December 2020

Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk prediction

1 reference

12 December 2020

Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

1 reference

12 December 2020

The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population

1 reference

12 December 2020

Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts

1 reference

12 December 2020

Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes

1 reference

12 December 2020

In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans

1 reference

12 December 2020

Techniques for noninvasive molecular imaging of atherosclerotic plaque.

1 reference

12 December 2020

The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.

1 reference

12 December 2020

Trained immunity: A program of innate immune memory in health and disease.

1 reference

12 December 2020

Imaging unstable plaque

1 reference

12 December 2020

Increased haematopoietic activity in patients with atherosclerosis.

1 reference

12 December 2020

In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes

1 reference

12 December 2020

PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia

1 reference

12 December 2020

S100A8/A9 increases the mobilization of pro-inflammatory Ly6Chigh monocytes to the synovium during experimental osteoarthritis.

1 reference

12 December 2020

Identifiers

DOI

10.1093/EURHEARTJ/EHX581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29069365%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

1 reference